Joaquin Solis, MD
Interventional Cardiology · Milwaukee, WINPI 1649221516
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,114 of the $1,469 with a category attached, or 75.8%. Siemens Medical Solutions USA, Inc. accounts for 85.0% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $1,248 and has fallen 94.5% since, to $69 in 2025. That places this record below the midpoint for interventional cardiology clinicians in WI, where the typical reported total is $3,713.
Across 11 payments — averaging $133.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Siemens Medical Solutions USA, Inc.$1K
- Shockwave Medical, Inc$111
- Medtronic$83
- AbbVie$26
Across 3 payments — averaging $7945.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Shockwave Medical, Inc$24K
What the payments were for
- Travel & lodging$1,11476%
- Food & beverage$35524%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 6 | $1,248 |
| Shockwave Medical, Inc | 1 | $111 |
| Medtronic | 3 | $83 |
| AbbVie | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,469 in reported general payments places this provider in the 30th percentile of 118 interventional cardiology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 455 | $495,403 |
| EntrestoSacubitril/Valsartan | 337 | $429,229 |
| JardianceEmpagliflozin | 230 | $262,545 |
| XareltoRivaroxaban | 87 | $98,868 |
| Repatha SureclickEvolocumab | 106 | $74,762 |
| BrilintaTicagrelor | 63 | $48,731 |
| Clonidine | 126 | $21,525 |
| Praluent PenAlirocumab | 13 | $13,724 |
| Atorvastatin Calcium | 989 | $9,633 |
| Repatha SyringeEvolocumab | 13 | $8,241 |
| Metoprolol Succinate | 645 | $7,681 |
| ClopidogrelClopidogrel Bisulfate | 719 | $6,740 |
| Fenofibrate | 14 | $6,029 |
| Ranolazine ErRanolazine | 65 | $5,962 |
| Losartan Potassium | 464 | $4,109 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Milwaukee
- Michael SalingerMilwaukee$216K
- Tanvir BajwaMilwaukee$106K
- Suhail AllaqabandMilwaukee$88K
- Saif AnwaruddinMilwaukee$80K
- Iyad AzzamMilwaukee$60K
- Montoya TaylorMilwaukee$48K
- Mina IskanderMilwaukee$41K
- Anna LarosaMilwaukee$38K
- Louie KostopoulosMilwaukee$26K
- Daniel JohnsrudMilwaukee$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.